Core Laboratories N.V. (CLB)

Core Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	14.91	15.12	15.43	17.7	13.81	11.09
Cash & Cash Equivalents	14.91	15.12	15.43	17.7	13.81	11.09
Cash Growth	-8.42%	-2.00%	-12.85%	28.23%	24.47%	-15.43%
Receivables	115.09	109.35	106.91	96.83	83.19	131.58
Inventory	70.71	71.7	60.45	45.44	38.15	50.16
Other Current Assets	28.33	26.96	28.92	29.08	30.7	28.4
Total Current Assets	229.05	223.14	211.7	189.06	165.85	221.24
Property, Plant & Equipment	152.16	153.47	157.41	172.34	181.68	199.2
Goodwill and Intangibles	106.25	106.37	106.93	107.58	108.03	230.88
Other Long-Term Assets	100.5	103.42	102.32	111.88	113.03	123.36
Total Long-Term Assets	358.9	363.26	366.65	391.8	402.73	553.44
Total Assets	587.95	586.4	578.35	580.85	568.58	774.67
Accounts Payable	32.49	33.51	45.85	29.73	23.03	35.61
Deferred Revenue	5.13	4.76	5.94	7.77	5.46	13.38
Current Debt	10.43	10.18	11.7	12.34	11.44	11.84
Other Current Liabilities	37.43	39.66	39.65	40.95	49.83	50.76
Total Current Liabilities	85.47	88.1	103.14	90.78	89.75	111.59
Long-Term Debt	201.85	205.21	210.69	237.92	315.54	369.94
Other Long-Term Liabilities	63.21	63.28	75.57	91.15	87.72	111
Total Long-Term Liabilities	265.07	268.49	286.27	329.07	403.26	480.94
Total Liabilities	350.53	356.59	389.4	419.85	493.01	592.53
Total Debt	212.28	215.39	222.39	250.26	326.98	381.78
Debt Growth	-9.79%	-3.15%	-11.14%	-23.46%	-14.36%	31.75%
Retained Earnings	123.51	120.76	85.95	68.35	50.46	160.54
Comprehensive Income	-5.16	-4.97	-3.78	-10.13	-7.2	-6.33
Shareholders' Equity	232.16	224.82	184.26	156.45	71.51	177.87
Net Cash / Debt	-197.37	-200.27	-206.96	-232.56	-313.17	-370.69
Net Cash Per Share	-4.14	-4.21	-4.42	-4.98	-7.04	-8.30
Working Capital	143.58	135.04	108.57	98.27	76.1	109.64
Book Value Per Share	4.95	4.82	3.98	3.40	1.61	4.01

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).